Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma.
- DOI
- 10.1200/po-26-00091
- Published
- 2026-06-08
- Container
- JCO Precis Oncol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/po-26-00091,
title = {Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma.},
author = {Milewski D and Fallatah A and Groff M and Rahmy A and Khan SR and Okafor C and Glassberg B and Chou HC and Heselmeyer-Haddad K and Wangsa D and Wangsa D and Kim Y and Isanogle K and Song Y and Zhang X and Thomas C and Difilippantonio S and Park JI and Wei JS and Hawley RG and Glod J and Khan J.},
year = {2026},
journal = {JCO Precis Oncol},
doi = {10.1200/po-26-00091},
url = {https://doi.org/10.1200/po-26-00091}
}RIS
TY - JOUR TI - Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma. AU - Milewski D AU - Fallatah A AU - Groff M AU - Rahmy A AU - Khan SR AU - Okafor C AU - Glassberg B AU - Chou HC AU - Heselmeyer-Haddad K AU - Wangsa D AU - Wangsa D AU - Kim Y AU - Isanogle K AU - Song Y AU - Zhang X AU - Thomas C AU - Difilippantonio S AU - Park JI AU - Wei JS AU - Hawley RG AU - Glod J AU - Khan J. PY - 2026 JO - JCO Precis Oncol DO - 10.1200/po-26-00091 UR - https://doi.org/10.1200/po-26-00091 ER -
APA
D, M., A, F., M, G., A, R., SR, K., C, O., B, G., HC, C., K, H., D, W., D, W., Y, K., K, I., Y, S., X, Z., C, T., S, D., JI, P., JS, W., RG, H., J, G., & J., K. (2026). Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma.. JCO Precis Oncol. https://doi.org/10.1200/po-26-00091
Source records
- europe-pmc · retrieved 2026-09-26T04:45:38.104Z